Vaisala - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Vaisala provides environmental measurement instruments and continuous monitoring systems for critical life science applications.  Whether you run cleanrooms, laboratories, incubators, environmental test chambers, warehouses, cold chain, or other critical environments in life science, or are responsible for the whole supply chain management, our solutions will help minimize downtime and maximize yield.

Reliable measurement of environmental parameters and fail-safe continuous monitoring with gap-free data is the key to high quality in processes, end products, and safety of people. Vaisala's measurement and monitoring solutions include humidity, temperature, dew point, carbon dioxide, differential and barometric pressure measurement instruments, continuous monitoring and alarming system, validation/mapping system, cold chain monitoring, support and service globally, including ISO17025 accredited calibrations. Vaisala's solutions combine measurement accuracy and stability with data protection in a way that complies with the strictest regulatory requirements.

Vaisala is a global leader in environmental and industrial measurement. Building on 78 years of experience, Vaisala contributes to a better quality of life by providing a comprehensive range of innovative observation and measurement products and services for chosen weather-related and industrial markets. Headquartered in Finland, Vaisala employs approximately 1500 professionals worldwide, serves customers in over 150 countries and has over 30 offices in 16 countries.

For more information visit www.vaisala.com/lifescience

Vaisala Oyj

Website: www.vaisala.com

E-mail: www.vaisala.com/requestinfo
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
FindPharma Custom Search

Click here